Product Images Temozolomide

NDC 75834-143-14 is a pack of Temozolomide capsules. These capsules contain 100 mg of temozolomide, which is prescribed for oral administration. The package insert provides recommendations for the use of varying capsule strengths in establishing daily dosage. The pharmacist should dispense these capsules in tight, light-resistant containers. The manufacturer is Nivagen Pharmaceuticals, Inc. and these capsules are made in Germany. The recommended storage temperature is 25°C (77°F) with excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].*

This is a description of Temozolomide capsules, USP, with each capsule containing 100 mg of the active ingredient. The capsules are for oral administration and are cytotoxic. The package insert should be consulted for recommendations on daily regimens. They should be stored at 25°C with excursions allowed between 15-30°C. They should be dispensed in tight, light-resistant containers and are manufactured by Nivagen Pharmaceuticals in Sacramento, CA. The NDC number is 75834-143-05, and the lot expiration date is not provided.*

This is a description for Temozolomide capsules, USP with 100mg dosage for oral administration. It is varnish-free, and each capsule contains 100mg temozolomide. Usual dose recommendations are included in the package insert. It is important not to open the capsules as they are cytotoxic. Special dispensing information for pharmacists is provided, and the medication is manufactured in Germany for Nivagen Pharmaceuticals, Inc. The Toll-free number for queries is 1-877-977-0687, and the capsules come in a pack of 14.*

This is a description of Temozolomide Capsules, USP, with a strength of 100mg, meant for oral administration. It is varnish-free and should be stored within a temperature range of 15-30°C (59-86°F). The capsules are cytotoxic and should not be opened. The accompanying directions should be read carefully, and the pharmacist should pay attention to the special dispensing information that is included. The capsules are manufactured by Nivagen Pharmaceuticals, Inc. in Germany, and their toll-free number is 1-877-977-0687.*

NDC 75834-144-14 is a package of Temozolomide capsules intended for oral administration. Each capsule contains 140 mg of temozolomide. It is a cytotoxic drug that requires careful reading of accompanying instructions. The usual dose may vary; the package insert recommends a daily regimen. It should be stored in a tight, light-resistant container at temperatures between 15-30°C. Nivagen Pharmaceuticals, Inc. manufactures it in Germany. In case of inquiries, call 1-877-977-0687.*

NDC 75834-144-05 is a container of Temozolomide capsules, which are cytotoxic and are meant for oral administration. Each of the 5 capsules contains 140 mg of temozolomide. The package insert provides recommendations on how to establish a daily regimen using varying capsule strengths. The capsules should be stored at between 15-30°C (59-86°F) at room temperature. Dispense in tight, light-resistant containers according to USP/NF standards. This product is manufactured in Germany for Nivagen Pharmaceuticals, Inc., Sacramento, CA, USA. Call their toll-free number for more information.*

Temozolomide is a medication available in capsule form for oral administration. It is varnish-free and should be stored at room temperature. The capsules are cytotoxic and should not be opened; rather, they should be swallowed whole. Each capsule contains 140 mg of the medication. Special dispensing information is included for pharmacists, and the accompanying directions should be read carefully. The usual dose recommendations can be found in the package insert. The medication is manufactured for Nivagen Pharmaceuticals and made in Germany.*

This is a description of Temozolomide Capsules, USP used for oral administration. The capsules are free of varnish and should be stored at 25°C (77°F) with permitted excursions to 15-30°C (59-86°F). Each capsule contains 140mg of the drug. It is specified that the capsules should not be opened and should be swallowed whole to avoid skin, eyes or nose contact. The package also includes special dispensing information for reviewing carefully. The manufacturer is Nivagen Pharmaceuticals based in Sacramento, USA, and the capsules are made in Germany.*

This is a description of Temozolomide capsules, a cytotoxic medication used for oral administration. Each capsule contains 180mg of temozolomide to be taken as recommended in a daily regimen with varying capsule strengths. The medication should be stored at controlled room temperature and dispensed in tight, light-resistant containers as defined by the USP/NF. Made in Germany for Nivagen Pharmaceuticals, Inc. with a toll-free contact number provided.*

NDC 75834-145-05 is a bottle of temozolomide capsules for oral administration. Each capsule contains 180mg of temozolomide, and the recommended dosage is included in the package insert. It is a cytotoxic medication and should be handled with care. The capsules should be stored at a controlled room temperature, and the pharmacist should dispense them in tight, light-resistant containers. Nivagen Pharmaceuticals, Inc. manufactures it in Germany for distribution and sales in Sacramento, CA, USA. For more information, refer to the accompanying instructions.*

This is a description of Temozolomide Capsules, USP with a strength of 180mg. It is an oral medication used in the treatment of various medical conditions. The medication should be stored at a temperature between 15-30°C. The medication label provides special dispensing information for pharmacists to review carefully. Each capsule contains 180mg temozolomide and the package contains 14 capsules. Users should swallow the capsule whole, and should not open it as it is cytotoxic. The manufacturer is Nivagen Pharmaceuticals, Inc.*

Temozolomide is a medication available in the form of 180mg capsules for oral administration and should be stored at a temperature between 15-30°C. It is indicated that each capsule contains 180mg of Temozolomide and is not recommended to be opened as it is cytotoxic. The package contains special dispensing information for pharmacists, which must be read carefully before dispensing the medication. This medication is manufactured by Nivagen Pharmaceuticals Inc. in Germany.*

Temozolomide Capsules, USP is a medication used for oral administration and containing 20mg of temozolomide per capsule. It is a cytotoxic drug, available in a package of 14 capsules. The usual dose can be found in the package insert, and pharmacists should dispense it in tight, light-resistant containers as per USP/NF definition. The manufacturer is Nivagen Pharmaceuticals, Inc. located in Sacramento, CA, and the medication is made in Germany. The lot number and expiration date are not available.*

NDC 75834-142-05 is a medication from Nivagen Pharmaceuticals, called Temozolomide, that comes in capsules for oral administration with a strength of 20mg per capsule. It is a cytotoxic medication and the accompanying R should be read and directions followed carefully. Its usage and dose depend on the recommendation mentioned in the package insert. It should be stored at 25°C with excursions permitted to 15-30°C. Additionally, it should be dispensed in tight and light-resistant containers by the pharmacist. This medication was made in Germany, and the toll-free number for Nivagen Pharmaceuticals, Inc. is 1-877-977-0687. The above text is a medical description of the medication Temozolomide.*

This is a package insert for Temozolomide Capsules, USP, with a strength of 20mg, intended for oral administration. The recommended storage temperature is between 15-30°C. Each capsule contains 20mg of temozolomide and the package includes 14 capsules. Instructions for use caution that the capsules should not be opened and if damaged, contact with skin, eyes, or nose should be avoided. The package includes special dispensing information specifically for pharmacists. This medication is a cytotoxic drug that should be used with careful consideration and alongside the accompanying directions. The manufacturer is Nivagen Pharmaceuticals, Inc with a toll-free number for customer support.*

This is a medication called Temozolomide that comes in 20mg capsules for oral administration. It should be stored at room temperature, and the pharmacist should review special dispensing information included. The capsules contain cytotoxic properties, and it is essential not to open them, but swallow them whole. Each capsule has 20mg of Temozolomide, and the package insert contains instructions for the recommended daily regimen. Manufactured in Germany for Nivagen Pharmaceuticals in Sacramento, CA, USA.*

NDC 75834-146-05 is a packaging of Temozolomide Capsules with each capsule containing 250 mg temozolomide for oral administration. It is a cytotoxic drug and needs to be used as per the R only directions carefully. The recommended dose information is provided in the package insert, and it is suggested to store the drug at 25°C (77°F) with permitted excursions to 15-30°C (59-86°F). It should be dispensed in tight, light-resistant containers as defined in the USP/NF by the pharmacist. Nivagen Pharmaceuticals, Inc. manufactures it in Germany with a Toll-free number of 1-877-977-0687 for any assistance.*

This is a description of Temozolomide Capsules, USP. The capsules are used for oral administration and must be stored at a controlled room temperature. Each capsule contains 250mg of temozolomide. It is important that the accompanying directions are read carefully, and the capsules must not be opened as it is cytotoxic. The drug must be swallowed whole to avoid contact with skin, eyes, or nose. This product is manufactured by Nivagen Pharmaceuticals in Germany. For further information, it is advised to refer to the package insert.*

NDC 75834-132-14 is a package of Temozolomide capsules for oral administration. The capsules are cytotoxic and contain 5mg temozolomide each. It is important to read the accompanying instructions carefully. The usual dose varies and it is recommended to consult the package insert. It should be stored at room temperature and dispensed in a tight, light-resistant container. This medication is manufactured for Nivagen Pharmaceuticals in Germany. Contact their toll-free number for more information.*

NDC 75834-132-05 is a medication known as Temozolomide. It is available in capsule form and is intended for oral administration. The medication is cytotoxic and must be used carefully as per the accompanying directions. Each capsule has 5mg of temozolomide. The package insert contains recommendations for the use of varying capsule strengths in establishing a daily dosage. The medication should be stored at a temperature of 25°C (77°F), with excursions permitted to 15-30°C (59-86°F). It must be dispensed in tight, light-resistant containers as defined in the USP/NF by a pharmacist. The medication is manufactured by Nivagen Pharmaceuticals, Inc. in Germany and distributed from Sacramento, CA, USA. The package contains a toll-free number for questions or concerns. Lot and expiration date information is also included.*

This is a description of Temozolomide Capsules, USP which is used for oral administration. It is important to store it between 15-30°C (59-86°F). Each capsule contains 5mg temozolomide and it is a cytotoxic drug so the capsules should not be opened and should be swallowed whole. The package insert should be consulted for the recommended daily regimen. The product is manufactured for Nivagen Pharmaceuticals, Inc. in Germany.*

This is a label for Temozolomide Capsules, USP for oral administration. It contains 5mg of Temozolomide per capsule and is available only through prescription. It is recommended to swallow whole without opening, and the pharmacist must review the special dispensing information before dispensing. The usual dose can be established according to the patient's condition, as described in the package insert. The manufacturer is Nivagen Pharmaceuticals Inc., located in Sacramento, USA, and the product was made in Germany. The storage temperature is between 15-30°C (59-86°F).*

This is a statistical analysis output for the ITT (intention-to-treat) population in terms of overall survival probability. The hazard ratio (HR) with a confidence interval of 95% is 0.63 (0.52-0.75), and the log-rank p-value is less than 0.0001. The time from randomization is presented in months.*